{"id":"W2564318420","doi":"10.1186/s40425-016-0173-6","title":"31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two","year":2016,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Columbia College; Caprion (Canada)","funders":"National Institute of Neurological Disorders and Stroke; Stand Up To Cancer; National Institutes of Health; Knight Cancer Institute, Oregon Health and Science University; Cancer Research Society; European Commission; U.S. Department of Defense; Breast Cancer Research Foundation; Oregon Health and Science University; Prostate Cancer Foundation; Movember Foundation; Cancer League of Colorado; Harry J. Lloyd Charitable Trust; National Cancer Institute; Dendreon Pharmaceuticals; Melanoma Research Alliance; Susan G. Komen for the Cure; Pharmaceutical Research and Manufacturers of America Foundation; Amgen; Collins Medical Trust","keywords":"Prostate cancer; Immunotherapy; Cancer immunotherapy; Myeloid cells; Cancer; Medicine; Gerontology; Immunology; Oncology; Cancer research; Myeloid; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001312985,0.0003111117,0.0008677856,0.00008340648,0.0002491471,0.00002170165,0.0003161632,0.0001917892,0.0001819499],"category_scores_gemma":[0.00005574862,0.0001732268,0.001568542,0.0002788927,0.0005476901,0.0001827822,0.00002613075,0.000192496,9.167692e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003172346,"about_ca_system_score_gemma":0.0008365205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007441422,"about_ca_topic_score_gemma":0.0002509947,"domain_scores_codex":[0.9975085,0.00007315964,0.001172963,0.0002609429,0.0005080223,0.000476398],"domain_scores_gemma":[0.9964725,0.0002902561,0.001798805,0.0003468246,0.001021374,0.00007018584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01084852,0.0002964287,0.02614914,0.00020623,0.005120338,1.990453e-7,0.001713503,0.000004836137,0.5656192,0.00002934803,0.00601054,0.3840017],"study_design_scores_gemma":[0.07208356,0.004518243,0.05608099,0.01042461,0.001056004,0.00003957342,0.001451067,0.00006901456,0.428767,0.000742394,0.4239808,0.0007867179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8998871,0.09140053,0.0003513389,0.004167115,0.001510794,0.00189326,0.0007009511,0.00002181415,0.0000670273],"genre_scores_gemma":[0.8708895,0.1168066,0.002031196,0.001489358,0.001039861,0.0006492113,0.00001290582,0.0002251446,0.006856298],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4179703,"threshold_uncertainty_score":0.7063983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01995262355944799,"score_gpt":0.3311051548978156,"score_spread":0.3111525313383676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}